Evidence map›Paper›PMID 33839738›Full record

ArticleLeukemia2021

External validation of the FIRST trial's simplified frailty score in a population-based cohort.

Hira S Mian, Smith Giri, Tanya M Wildes, Amaris K Balitsky, Arleigh McCurdy, Gregory R Pond, Branavan Sivapathasundaram, Hsien Seow

Abstract readLetterValidation Study
PubMed Publisher
In one paragraph

Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hira S MianJuravinski Cancer Center, Department of Oncology, McMaster University, Hamilton, ON, Canada. mianh@hhsc.ca.ORCID http://orcid.org/0000-0003-1584-1067
Smith GiriInstitute for Cancer Outcomes and Survivorship, Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham AL, USA.
Tanya M WildesCancer & Aging Research Group, St. Louis, MO, USA.
Amaris K BalitskyJuravinski Cancer Center, Department of Oncology, McMaster University, Hamilton, ON, Canada.
Arleigh McCurdyDepartment of Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Gregory R PondJuravinski Cancer Center, Department of Oncology, McMaster University, Hamilton, ON, Canada.
Branavan SivapathasundaramMcMaster University, Hamilton, ON, Canada.
Hsien SeowJuravinski Cancer Center, Department of Oncology, McMaster University, Hamilton, ON, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PhenotypeActivities of Daily LivingAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCanadaCohort StudiesFemaleFollow-Up StudiesFrailtyGeriatric AssessmentHumansMaleMultiple MyelomaPrognosisSurvival Rate

Identifiers

PMID33839738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.